金龙固本合剂治疗支气管哮喘缓解期113例

目的： 观察金龙固本合剂治疗支气管哮喘缓解期（宿痰伏肺证）的临床疗效。 方法： 将223例支气管哮喘缓解期患者随机分为治疗组和对照组，治疗组采用金龙固本合剂口服治疗，对照组不用药物干预，疗程均为120 d，随访期1年。观察两组治疗前后国际哮喘控制测试表（ACT）评分、1秒钟用力呼气量（FEV₁）和最大呼气流量（PEF）变化。 结果： 治疗组可显著改善哮喘缓解期患者的ACT评分、FEV₁和PEF，且疗效持久（P<0.01）；治疗组与对照组比较ACT评分和FEV₁有显著差异（P < 0.01）。 结论： 金龙固本合剂治疗支气管哮喘缓解期患者（宿痰伏肺证）具有良好疗效。

Observation of Curative Effect of Jinlong Guben Mixture on Treating Asthma in Remission Stage in 113 Cases

Objective: To observe the effect of Jinlong Guben mixture on treating asthma in remission stage (Latent phlegm in lung syndrome). Method: One hundred and thirteen patients of asthma on remission stage were randomized to the control group and the treatment group. The treatment group were given Jinlong Guben mixture. The control group were given nothing to be coated, course of treatment were both 120 days and follow-up period were both 360 days. To observe the change of asthma control test (ACT) scores,forced expiratory volume in 1 second(FEV₁) and peak expiratory flow(PEF). Result: After treatment,ACT scores,FEV₁ and PEF of the treatment group were markedly increased, with statistical significance (P < 0.01),and can have long-lasting and stable effect. There were significant differences in ACT scores and FEV₁ of two groups, with statistical significance (P < 0.01). Conclusion: Jinlong Guben mixture has a good curative effect on treating asthma in remission stage (Latent phlegm in lung syndrome).